Biotech · Public company · Staten Island, NY, US
Acurx Pharmaceuticals, Inc.
Ticker ACXP · SEC CIK 0001736243
Track this companyFree. Adds Acurx Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- IbezapolstatPhase 2 · Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
- IbezapolstatPhase 2 · Clostridium Difficile Infection RecurrenceClinicalTrials.gov · fetched Nov 12, 2026
- VancomycinPhase 2 · Clostridium Difficile InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile InfectionPHASE2 · RECRUITING · started Sep 25, 2026ClinicalTrials.gov NCT07513285 · fetched Nov 12, 2026
- ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile InfectionPHASE2 · COMPLETED · started Mar 6, 2020ClinicalTrials.gov NCT04247542 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 16, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- S-1 · FORM S-1SEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- S-1 · FORM S-1SEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 16, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 9, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Feb 2, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026